HTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference
TUCSON, Ariz., Sept. 06, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced its management will present at the Rodman and Renshaw 19th Annual Global Investment Conference in New York City on Monday, September 11, 2017, at 5:00 p.m. Eastern Time.
A live audio webcast of the presentation can be accessed by visiting the “Investors” section of the Company’s website at: http://www.htgmolecular.com. The webcast will be available on HTG's website for 90 days following the completion of the presentation.
About HTG:
Headquartered in Tucson, Arizona, the mission of HTG Molecular Diagnostics (HTG) is to empower precision medicine at the local level. The company’s HTG EdgeSeq technology, which automates sample and targeted library preparation for next-generation sequencing, received its first US Patent in 2014. Continuous improvements led to the 2017 launch of its new direct-target sequencing chemistry for DNA analysis. Additional information is available at www.htgmolecular.com.
CONTACT: Ashley Robinson LifeSci Advisors, LLC 617-775-5956 arr@lifesciadvisors.com TJ Johnson President/CEO HTG Molecular Diagnostics 520-547-2827 x130 tjjohnson@htgmolecular.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
